Medicamen Biotech has an EPS of $11.82. In 2022, the company made an earnings per share (EPS) of $12.19. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | $11.82 | -3.04% |
2022 | $12.19 | 22.76% |
2021 | $9.93 | -9.23% |
2020 | $10.94 | - |